Younossi Z M
The Cleveland Clinic Foundation, Department of Gastroenterology, Desk S-40, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Curr Gastroenterol Rep. 1999 Feb-Mar;1(1):57-62. doi: 10.1007/s11894-999-0088-1.
The definition of nonalcoholic fatty liver disease has evolved in recent years. Today, it is considered a nonspecific term encompassing several clinicopathologic entities (steatosis alone, steatonecrosis, steatohepatitis and histologic alcoholic-like hepatitis) that are similar to alcoholic liver disease. Studies of nonalcoholic fatty liver disease have come to conflicting conclusions about the course of the disease. It can be argued that the disparate results are largely the result of nonuniform definitions. When histologic features such as hepatocyte ballooning, necrosis, and Mallory hyaline are seen, nonalcoholic fatty liver disease has been shown to be associated with an aggressive outcome. Steatosis alone, in contrast, appears to be benign. The current understanding of nonalcoholic fatty liver disease, the limited treatments available, and two theories of the pathogenesis of the disease are also reviewed here.
近年来,非酒精性脂肪性肝病的定义不断演变。如今,它被视为一个非特异性术语,涵盖了几种临床病理实体(单纯性脂肪变性、脂肪坏死、脂肪性肝炎以及组织学上类似酒精性肝炎的病变),这些实体与酒精性肝病相似。关于非酒精性脂肪性肝病的病程,相关研究得出了相互矛盾的结论。可以认为,这些不同的结果很大程度上是由于定义不统一所致。当出现肝细胞气球样变、坏死和马洛里小体等组织学特征时,非酒精性脂肪性肝病已被证明与不良预后相关。相比之下,单纯性脂肪变性似乎是良性的。本文还将对非酒精性脂肪性肝病的当前认识、现有的有限治疗方法以及该疾病发病机制的两种理论进行综述。